Skip to main content
Advertisement
Advertisement
LBRX
LBRX logo
LB Pharmaceuticals Inc Common Stock
42.01
USD
Sponsored
+3.92
+10.29%
Nov 06, 15:58 UTC -5
Closed
exchange

After-Market

41.34

-0.67
-1.61%

LB Pharmaceuticals Inc Common Stock (LBRX) Profile

LB Pharmaceuticals Inc Common Stock Profile

About

LB Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and other neuropsychiatric diseases. LB Pharmaceuticals is based in NEW YORK.

Info & Links

CEO

Heather Turner

Headquarters

One Pennsylvania Plaza, Suite 1025
New York, NY 10119, UNITED STATES

Sector

Medical

Auditor

BDO USA, P.C.

Share holders

--

Employees

27

LB Pharmaceuticals Inc Common Stock Statistics

Valuation Measures

Market Capitalization2

1.33B

Enterprise Value

1.12B

Enterprise Value/EBITDA(ttm)

-7.34

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.37

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-25.92%

Return on Invested Capital(ttm)

-25.51%

Return on Assets(ttm)

-24.68%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-152.42M

Net Income Available to Common(ttm)

-141.20M

Diluted EPS(ttm)

-4.62

Share Statistics

Beta (5Y Monthly)

0.82

52-Week Change

170.86%

S&P 500 52-Week Change

14.03%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

32.36M

Dividend Yield

0.00%

Float4

30.39M

% Held by Insiders

5.80%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

403.76M

Total Cash Per Share(mrq)

12.48

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

15.08%

Quick Ratio(mrq)

15.08%

Book Value Per Share(mrq)

11.59

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.02

Free Cash Flow(ytd)

-61.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement